A post-hoc physiological analysis of fifteen critically ill patients with morbid obesity found that PSV-PEEP lowered work of ...

Medicare is testing the use of AI to conduct prior authorizations to target wasteful medical spending ...

Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basisQ1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP ...

Linde on Thursday delivered a top- and bottom-line beat, with sales, operating profit, and earnings all representing ...

Linde raised third-quarter revenue by 9.2% year-on-year to a record $9.4 billion and reported adjusted EPS of $4.59, above ...

Aetherion Technologies Inc. (“Aetherion") (TSX: AETR / Nasdaq: AETR), announces that the Company will release Q3 2026 financial results on Thursday, November 12, 2026, after market close. A conference ...

This release removes the mention of Cleveland Clinic Weston.Partnership unites the ReBalU Protocol, Vivos's sleep platform, and a new test for cells primed for chronic disease, reaching nearly 500,000 ...

U.S. Attruby net product revenue (up approximately $31 million sequentially and $145 million year over year). Loss from operations was $11.6 million, driven by increased revenue and a one-time $75.0 ...

Welcome to the Align Third Quarter 2026 Earnings Call. [Operator Instructions] Please note, this conference is being recorded ...

Eli Lilly and Company remains a Buy, as its Q3 results show strong revenue growth and rising Mounjaro and Zepbound sales.

Shares of railcar products and services provider Trinity (NYSE:TRN) jumped 10.6% in the afternoon session after the company ...

Japan studies found visual-acuity improvement; Kiora targets a multinational Phase 3 trial in 2027, subject to funding and ...